Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Insiya Jafferji

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Immunology Reviews|July 24, 2009
Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy CellsRobert A Eagle, Insiya Jafferji, Alexander D Barrow
The Journal of General Virology|March 27, 2009
Inhibition of epidermal growth factor receptor (EGFR) expression by human cytomegalovirus correlates with an increase in the expression and binding of Wilms' Tumour 1 protein to the EGFR promoterInsiya Jafferji, Mark Bain, Christine King, et al.
Cancer Treatment and Research|May 13, 2022
Lag3: From Bench to BedsideFrancesca Aroldi, Reem Saleh, Insiya Jafferji, et al.
European Journal of Immunology|August 7, 2009
ULBP6/RAET1L is an additional human NKG2D ligandRobert A Eagle, James A Traherne, James R Hair, et al.
International Journal of Cancer|January 8, 2010
ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patientsRoger W McGilvray, Robert A Eagle, Phil Rolland, et al.
Biomicrofluidics|June 28, 2013
ApoStream(™), a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from bloodVishal Gupta, Insiya Jafferji, Miguel Garza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoeditingRoger W McGilvray, Robert A Eagle, Nicholas F S Watson, et al.
Plos One|February 19, 2009
Cellular expression, trafficking, and function of two isoforms of human ULBP5/RAET1GRobert A Eagle, Gillian Flack, Anthony Warford, et al.
BMC Cancer|January 20, 2012
NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational studyEsther M de Kruijf, Anita Sajet, Johanna G H van Nes, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Immunology Reviews|July 24, 2009
Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy CellsRobert A Eagle, Insiya Jafferji, Alexander D Barrow
The Journal of General Virology|March 27, 2009
Inhibition of epidermal growth factor receptor (EGFR) expression by human cytomegalovirus correlates with an increase in the expression and binding of Wilms' Tumour 1 protein to the EGFR promoterInsiya Jafferji, Mark Bain, Christine King, et al.
Cancer Treatment and Research|May 13, 2022
Lag3: From Bench to BedsideFrancesca Aroldi, Reem Saleh, Insiya Jafferji, et al.
European Journal of Immunology|August 7, 2009
ULBP6/RAET1L is an additional human NKG2D ligandRobert A Eagle, James A Traherne, James R Hair, et al.
International Journal of Cancer|January 8, 2010
ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patientsRoger W McGilvray, Robert A Eagle, Phil Rolland, et al.
Biomicrofluidics|June 28, 2013
ApoStream(™), a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from bloodVishal Gupta, Insiya Jafferji, Miguel Garza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoeditingRoger W McGilvray, Robert A Eagle, Nicholas F S Watson, et al.
Plos One|February 19, 2009
Cellular expression, trafficking, and function of two isoforms of human ULBP5/RAET1GRobert A Eagle, Gillian Flack, Anthony Warford, et al.
BMC Cancer|January 20, 2012
NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational studyEsther M de Kruijf, Anita Sajet, Johanna G H van Nes, et al.
Pageof 1